Clinical Trial Update: Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of levetiracetam for inpatient treatment of Alcohol Withdrawal Syndrome; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Withdrawal Syndrome

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Alcohol Withdrawal Syndrome | Phase 3 | Status: COMPLETED